ONWARD to Recovery - Episode 105

from U2FP CureCast · host Matthew Rodreick & Jason Stoffer

Today's episode is my conversation with Dave Marver, the CEO of ONWARD. No doubt you've heard of ONWARD. We discuss the recent news about their transcutaneous stimulation device and their effort to gain regulatory approval, along with the results from their Uplift TRIAL. You'll find links to the trial and related articles on our website to help understand what that is. More info: https://u2fp.org/get-educated/curecast/episode-105.html

Episode metadata supplied by the publisher feed · Published Jun 21, 2024

Embed this episode

Attribution link and audio player

Ready to play

ONWARD to Recovery - Episode 105

0:00 42:49

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of U2FP CureCast?

This episode is 42 minutes long.

When was this U2FP CureCast episode published?

This episode was published on June 21, 2024.

Can I download this U2FP CureCast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!